Skip to content
Menu

OnKure Therapeutics Q3 EPS $(0.36) Misses $(0.34) Estimate

Benzinga Newsdesk 1 week ago

NewsEarningsEarnings Misses

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

OnKure Therapeutics (NASDAQ:OKUR) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.34) by 5.88 percent. This is a 66.97 percent increase over losses of $(1.09) per share

OnKure Therapeutics (NASDAQ:OKUR) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.34) by 5.88 percent. This is a 66.97 percent increase over losses of $(1.09) per share from the same period last year.

Read at benzinga.com